Avanos Medical (AVNS) EBT Margin Growth (3y) (2016 - 2026)

Avanos Medical (AVNS) EBT Margin Growth (3y) (2016 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (3y) (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -305.00
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -9.00
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 55.00
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 923.00
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -480.00
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 1,391.00
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 2,114.00
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -176.00
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Avanos Medical 1.16 Bn 1.10 Bn 94.20 Mn 988.00

Historic Data

Download Data
DateValue
Mar 31, 2026 988.00
Dec 31, 2025 -721.00
Sep 30, 2025 -654.00
Jun 30, 2025 -4,782.00
Mar 31, 2025 209.00
Dec 31, 2024 -16,961.00
Sep 30, 2024 411.00
Jun 30, 2024 763.00
Mar 31, 2024 876.00
Dec 31, 2023 3,205.00
Sep 30, 2023 74.00
Jun 30, 2023 59.00
Mar 31, 2023 -405.00
Dec 31, 2022 1,130.00
Sep 30, 2022 1,771.00
Jun 30, 2022 1,101.00
Mar 31, 2022 1,947.00
Dec 31, 2021 -5,899.00
Sep 30, 2021 -156.00
Jun 30, 2021 -471.00